Catecholamines in neuroblastoma: Driver of hypertension, or solely a marker of disease?
Matthew HardingRebecca J DeyellTom Blydt-HansenPublished in: Cancer reports (Hoboken, N.J.) (2021)
Although multifactorial, hypertension in neuroblastoma often has a neuroendocrine component. Excess normetanephrine production in neuroblastoma may be a more common hypertensive mechanism than previously appreciated. Urinary normetanephrine elevation could suggest potential neuroendocrine-mediated hypertension.